Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-08

Clinical Trial Update: IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches [Phase 4]

View source ↗

Summary

This Phase 4 trial update outlines IRONICA, a study comparing oral and IV iron repletion in patients with heart failure and iron deficiency/iron-deficiency anem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous iron formulation (ferric carboxymaltose) (Ferric carboxymaltose)
  • Oral iron supplement (ferrous sulfate) (Ferrous sulfate)

Snippet

Sponsor: Syed Hamza Mufarrih | Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF) | Phase 4 | Status: RECRUITING